These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 3076501

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Serum magnesium in insulin-dependent diabetics and healthy subjects in relation to insulin secretion and glycemia during glucose-glucagon test.
    Menzel R, Pusch H, Ratzmann GW, Besch W, Förster F, Albrecht G, Ruhnke R.
    Exp Clin Endocrinol; 1985 Feb; 85(1):81-8. PubMed ID: 3886415
    [Abstract] [Full Text] [Related]

  • 24. Insulin and glucagon secretion are suppressed equally during both hyper- and euglycemia by moderate hyperinsulinemia in patients with diabetes mellitus.
    Murayama Y, Kawai K, Watanabe Y, Yoshikawa H, Yamashita K.
    J Clin Endocrinol Metab; 1989 May; 68(5):925-31. PubMed ID: 2654170
    [Abstract] [Full Text] [Related]

  • 25. Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus.
    Orwoll E, Riddle M, Prince M.
    Am J Clin Nutr; 1994 May; 59(5):1083-7. PubMed ID: 8172095
    [Abstract] [Full Text] [Related]

  • 26. Defining the role of GLP-1 in the enteroinsulinar axis in type 2 diabetes using DPP-4 inhibition and GLP-1 receptor blockade.
    Aulinger BA, Bedorf A, Kutscherauer G, de Heer J, Holst JJ, Göke B, Schirra J.
    Diabetes; 2014 Mar; 63(3):1079-92. PubMed ID: 24296715
    [Abstract] [Full Text] [Related]

  • 27. Effects of nonglucose nutrients on insulin secretion and action in people with pre-diabetes.
    Bock G, Dalla Man C, Campioni M, Chittilapilly E, Basu R, Toffolo G, Cobelli C, Rizza R.
    Diabetes; 2007 Apr; 56(4):1113-9. PubMed ID: 17395750
    [Abstract] [Full Text] [Related]

  • 28. Glucagon-stimulated insulin secretion in patients with type 2 diabetes mellitus: support for the concept of glucose toxicity.
    Wolffenbuttel BH, Menheere PP, Nijst L, Rondas-Colbers GJ, Sels JP, Nieuwenhuijzen Kruseman AC.
    Neth J Med; 1992 Jun; 40(5-6):277-82. PubMed ID: 1436266
    [Abstract] [Full Text] [Related]

  • 29. [An evaluation of insulin requirement of diabetic patients by glucagon test].
    Kunihiro K.
    Fukuoka Igaku Zasshi; 1987 Apr; 78(4):150-63. PubMed ID: 3301604
    [No Abstract] [Full Text] [Related]

  • 30. Inhibitory effect of enkephalin on insulin secretion in healthy subjects and in non insulin-dependent diabetic subjects.
    Giugliano D, Quatraro A, Consoli G, Ceriello A, Torella R, D'Onofrio F.
    Metabolism; 1987 Mar; 36(3):286-9. PubMed ID: 3547015
    [Abstract] [Full Text] [Related]

  • 31. Eight weeks of treatment with long-acting GLP-1 analog taspoglutide improves postprandial insulin secretion and sensitivity in metformin-treated patients with type 2 diabetes.
    Gastaldelli A, Nauck MA, Balena R.
    Metabolism; 2013 Sep; 62(9):1330-9. PubMed ID: 23831441
    [Abstract] [Full Text] [Related]

  • 32. Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1.
    Sonne DP, Rehfeld JF, Holst JJ, Vilsbøll T, Knop FK.
    Eur J Endocrinol; 2014 Oct; 171(4):407-19. PubMed ID: 24986531
    [Abstract] [Full Text] [Related]

  • 33. Postprandial glucose, insulin and incretin responses to different carbohydrate tolerance tests.
    Deng Y, Zhang Y, Zheng S, Hong J, Wang C, Liu T, Sun Z, Gu W, Gu Y, Shi J, Yao S, Wang W, Ning G.
    J Diabetes; 2015 Nov; 7(6):820-9. PubMed ID: 25395350
    [Abstract] [Full Text] [Related]

  • 34. Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency.
    Prando R, Odetti P, Melga P, Giusti R, Ciuchi E, Cheli V.
    Diabetes Metab; 1996 Jun; 22(3):185-91. PubMed ID: 8697306
    [Abstract] [Full Text] [Related]

  • 35. The effect of various blood glucose levels on post-glucagon C-peptide secretion in type 2 (non insulin-dependent) diabetes.
    Nosari I, Lepore G, Maglio ML, Cortinovis F, Pagani G.
    J Endocrinol Invest; 1992 Feb; 15(2):143-6. PubMed ID: 1569291
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion.
    Lee WJ, Ser KH, Chong K, Lee YC, Chen SC, Tsou JJ, Chen JC, Chen CM.
    Surgery; 2010 May; 147(5):664-9. PubMed ID: 20004451
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance.
    Mitrakou A, Kelley D, Mokan M, Veneman T, Pangburn T, Reilly J, Gerich J.
    N Engl J Med; 1992 Jan 02; 326(1):22-9. PubMed ID: 1727062
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.